UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT PURSUANT
TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): December 24, 2013
 
Pharma-Bio Serv, Inc.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
(State or Other Jurisdiction of Incorporation)
 
0-50956
20-0653570
(Commission File Number)
(I.R.S. Employer Identification No.)

6 Road 696, Dorado, Puerto Rico
00646
(Address of Principal Executive Offices)
(Zip Code)

(787) 278-2709
(Registrant’s Telephone Number, Including Area Code)
 
 
(Former Name or Former Address, if Changed Since Last Report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 
 
 
 
 
 
Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 24, 2013, the board of directors (the "Board") of Pharma-Bio Serv, Inc. (the "Company") appointed Nélida Plaza ("Ms. N. Plaza") as Chief Operating Officer of the Company, effective January 1, 2014.  Ms. N. Plaza will also continue to serve as Secretary of the Company.  Ms. N. Plaza previously served as the Company's Acting President and Chief Executive Officer from January 2013 until December 31, 2013, Vice President of Operations of Pharma-Bio Serv PR, Inc. from January 2004 until December 31, 2013, and the Company's President of Puerto Rico Operations from December 2009 until December 31, 2013.
 
Also, on December 24, 2013, the Board appointed Elizabeth Plaza ("Ms. E. Plaza") as Principal Executive Officer of the Company for purposes of Securities and Exchange Commission reporting, effective January 1, 2014.  Ms. E. Plaza will also continue to serve as Chairman of the Board.

On December 31, 2013, the Company entered into a Consulting Agreement with Strategic Consultants International, LLC (the “Consultant”) and Ms. E. Plaza, effective as of January 1, 2014.  Pursuant to the Consulting Agreement, the Consultant will consult with the Board regarding the Company’s strategic initiatives, company services, management, operations and other matters as may be requested from time to time by the Board.  Pursuant to the Consulting Agreement, the Consultant will receive a monthly fee of $42,000 during the one year term of the Consulting Agreement.  Additionally, Ms. E. Plaza will receive a company automobile and such insurance as she was provided by the Company during her last year of employment with the Company.  The Consulting Agreement also included standard provisions relating to non-competition, confidentiality, and nondisparagement.  A copy of the Consulting Agreement is attached as Exhibit 10.1 to this report and is incorporated herein by this reference.

Ms. N. Plaza's and Ms. E. Plaza's biographical information is included in the sections titled "Management" and "Election of Directors," respectively, in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 11, 2013 (the “Proxy Statement”) and is incorporated by reference into this Item 5.02.  Related party transaction information relating to Ms. E. Plaza is included in the sections titled “Employment Agreements – Elizabeth Plaza - Consulting Agreement” and “Certain Relationships and Related Transactions” in the Proxy Statement, and in the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 23, 2013, and are incorporated by reference into this Item 5.02.  Ms. N. Plaza and Ms. E. Plaza are sisters.  Other than as described in those filings, there are no related party transactions between the Company and Ms. N. Plaza or Ms. E. Plaza, nor are there any other family relationships between the Company's directors or officers and Ms. N. Plaza or Ms. E. Plaza.

Item 9.01.  Financial Statements and Exhibits.
(d)
                  
Exhibit No.      Exhibit Description
10.1  Consulting Agreement, effective January 1, 2014, between Pharma-Bio Serv Inc., Strategic Consultants International, LLC and Elizabeth Plaza.
 
 
 
2

 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  PHARMA-BIO SERV, INC.  
       
Date:  December 31, 2013 
By:
/s/ Pedro J. Lasanta  
    Pedro J. Lasanta  
   
Chief Financial Officer
 
       

                                                                         
 
3

 
EXHIBIT INDEX
 
Exhibit No.      Exhibit Description
10.1  Consulting Agreement, effective January 1, 2014, between Pharma-Bio Serv Inc., Strategic Consultants International, LLC and Elizabeth Plaza.

 
 
4


 
Exhibit 10.1
 
CONSULTING AGREEMENT
 
This Consulting Agreement (the "Agreement") is entered into by Pharma-Bio Serv, Inc., a Delaware corporation (the "Company"), Strategic Consultants International, LLC, a Puerto Rico registered Limited Liability Corporation (the “Consultant"), and Elizabeth Plaza, residing in Dorado, Puerto Rico (“Plaza”), effective as of January 1, 2014.

WHEREAS, the Company desires to engage the Consultant to provide advice and assistance to the Company’s Board of Directors (the “Board”) and the Company’s Operations Management Team, and the Consultant is willing to provide such services for the Company, as more particularly described herein.
 
NOW, THEREFORE, the parties agree as follows:
 
1.   Services to Be Performed . Consultant will consult with the Board regarding the Company’s strategic initiatives, company services, management, operations and other matters as may be requested from time to time by the Board (the "Services"). Consultant shall report directly to the Board.  The Consultant agrees to use its best efforts in the performance of the Services under this Agreement. The Consultant shall cooperate with the Company’s personnel and shall observe all Company rules, including specifically those relating to discrimination and harassment, security and confidentiality.
 
2.   Term . This Agreement will have a term commencing as of January 1, 2014 through December 31, 2014 (the "Term").
 
3.   Independent Contractor Status . It is the express intention of the parties hereto that, for purposes of the Agreement, the Consultant is and shall remain an independent contractor and not an employee of the Company.
 
4.   Performance of Services . Consultant shall have the right to control and determine the time, place, methods, manner and means of performing the Services; provided, however, that Consultant shall ensure that Plaza is the only individual who shall be assigned to perform the Services.  In performing the Services, the amount of time devoted by Consultant on any given day will be entirely within Consultant's control, and the Company will rely on Consultant to devote the number of hours as are necessary to fulfill the requirements of the Agreement.  However, the Services contemplated herein must meet the Company’s standards and approval.
 
(a)   Non-Exclusivity . Except as set forth in this Agreement, Consultant retains the right to contract with other companies or entities for consulting services. Likewise, the Company retains a reciprocal right to contract with other companies and/or individuals for consulting services without restriction. Notwithstanding the foregoing, neither the Consultant nor Plaza shall engage in any activities, whether for compensation or otherwise, that would constitute a direct conflict of interest with its duties for Company.
 
(b)   Taxes . Since Consultant will be an independent contractor during the Term, all compensation under this Agreement shall be paid to Consultant without the Company withholding any payroll taxes or deductions and shall be reported by the Company as required by taxing authorities.
 
(c)   Other Covered Expenses . During the Term of this Agreement, Plaza shall be entitled to receive (i) such insurance, including major health insurance and life insurance, as the Company provided Plaza during her last year of employment with the Company and (ii) a company automobile as the Company provided Plaza during her last year of employment with the Company. Consultant shall be solely responsible for all state and federal income taxes, unemployment insurance, social security taxes and state disability insurance and for maintaining adequate workers’ compensation insurance coverage to the extent legally required.
 
 
 

 
 
5.   Compensation . For the full and proper performance of this Agreement, the Company agrees to compensate Consultant a monthly retainer fee of $42,000 during the Term.
 
6.   Expenses . Consultant shall be reimbursed for all reasonable out-of-pocket expenses incurred by Consultant in the course of performing its services hereunder, upon the submission of an expense report in which adequate support is provided for the expenses to be reimbursed.
 
7.   Covenant Not To Compete .  During the Term of this Agreement, neither Consultant nor Plaza will, directly or indirectly, engage in any business in the United States or Puerto Rico whether as an officer, director, consultant, partner, guarantor, principal, agent, employee, advisor or in any manner, which directly competes with the business of the Company, provided, however, that nothing in this Section 7 shall be construed to prohibit the Consultant or Plaza from owning an interest of not more than five (5%) percent of any public company engaged in such activities.
 
8.   Non-Disparaging Statements .  Neither the Consultant nor Plaza will, during or after the Term of this Agreement, make any disparaging statements concerning the Company, its business, officers, directors and employees that could injure, impair, damage or otherwise affect the relationship between the Company, on the one hand, and any of the Company’s employees, suppliers, customers, clients or any other person with which the Company has or may conduct business or otherwise have a business relationship of any kind and description.  The Company will not make any disparaging statements concerning Consultant or Plaza; provided, however, that this sentence shall not be construed to prohibit the Company from giving factual information concerning Consultant or Plaza in response to inquiries that the Company believes are bona fide.
 
9.   Trade Secrets and Proprietary Information .
 
(a)   Consultant and Plaza recognize and acknowledge that the Company, through the expenditure of considerable time and money, has developed and will continue to develop in the future information concerning customers, clients, marketing, products, services, business, research and development activities and operational methods of the Company and its customers or clients, contracts, financial or other data, technical data or any other confidential or proprietary information possessed, owned or used by the Company, the disclosure of which could or does have a material adverse effect on the Company, its businesses, any business in which it proposes to engage, its operations, financial condition or prospects and that the same are confidential and proprietary and considered “confidential information” of the Company for the purposes of this Agreement. Consultant and Plaza agree that they will not, during or after the Term of this Agreement, without the consent of the Board make any disclosure of confidential   information to any person, partnership, corporation or entity either during or after the Term of this Agreement, except that nothing in this Agreement shall be construed to prohibit Consultant or Plaza from using or disclosing (a) if such disclosure is necessary in the normal course of the Company’s business in accordance with policies or instructions or authorization from the Board, (b) Consultant or Plaza can demonstrate that such information shall have (i) become public knowledge other than by or as a result of disclosure by a person not having a right to make such disclosure, (ii) been developed by Consultant or Plaza independent of any of the Company’s confidential or proprietary information or (iii) been disclosed to Consultant or Plaza by a person not subject to a confidentiality agreement with or other obligation of confidentiality to the Company.
 
(b)   In the event that any confidential information is required to be produced by Consultant or Plaza pursuant to legal process, Consultant or Plaza shall give the Company notice of such legal process within a reasonable time, but not later than ten business days prior to the date such disclosure is to be made, unless Consultant or Plaza has received less notice, in which event Consultant or Plaza shall immediately notify the Company.  The Company shall have the right to object to any such disclosure, and if the Company objects (at the Company’s cost and expense) in a timely manner so that Consultant or Plaza is not subject to penalties for failure to make such disclosure, Consultant or Plaza shall not make any disclosure until there has been a court determination on the Company’s objections.  If disclosure is required by a court order, final beyond right of review, or if the Company does not object to the disclosure, Consultant or Plaza shall make disclosure only to the extent that disclosure is required by the court order, and Consultant or Plaza will exercise reasonable efforts at the Company’s expense, to obtain reliable assurance that confidential treatment will be accorded the confidential information.
 
 
2

 
 
(c)   Neither Consultant nor Plaza shall, upon expiration or termination of the Term, or earlier at the request of the Company, turn over to the Company or destroy all documents, papers, computer disks or other material in Consultant’s or Plaza’s possession or under Consultant’s or Plaza’s control which may contain or be derived from confidential information.  To the extent that any confidential information is on Consultant’s or Plaza’s hard drive or other storage media, they shall, upon the request of the Company, cause either such information to be erased from their computer disks and all other storage media or otherwise take reasonable steps to maintain the confidential nature of the material.
(d)   Consultant and Plaza further realize that any trading in the Company's common stock or other securities or aiding or assisting others in trading in the Company's common stock or other securities, including disclosing any non-public information concerning the Company to a person who uses such information in trading in the Company's common stock or other securities, constitutes a violation of federal and state securities laws.  Neither Consultant nor Plaza will engage in any transactions involving the Company's common stock or other securities while in the possession of material non-public information.
 
(e)   For the purposes of Sections 7, 8 and 9 of this Agreement, the term “Company” shall include the Company, its subsidiaries and affiliates.
 
10.   Warranties . Consultant will assume sole responsibility for its compliance with applicable federal and state laws and regulations, and shall rely exclusively upon its own determination, or that of its legal advisers, that the performance of services and the receipt of fees hereunder comply with such laws and regulations.
 
11.   Non-Assignability of Contract . The parties shall not have the right to assign any of the contractual rights or delegate any of the duties under this Agreement without the express written consent of the parties.
 
12.   Governing Law . This Agreement shall be governed by and construed in accordance with the laws of Commonwealth of Puerto Rico.
 
13.   Severability . In the event any provision of this Agreement shall be held invalid, the same shall not invalidate or otherwise affect in any respect any other term or terms of this Agreement, which term or terms shall remain in full force and effect.
 
14.   Amendment . This Agreement may be amended or modified only by a written instrument executed by both the Company and Consultant.
 
15.   Complete Agreement . This Agreement contains the entire understanding between the parties and supersedes, replaces and takes precedence over any prior or contemporaneous understanding or oral or written agreement between the parties respecting the subject matter of this Agreement. There are no representations, agreements, arrangements, nor understandings, oral or written, between the parties hereto relating to the subject matter of this Agreement which are not fully expressed herein.
 
16.   Counterparts . This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon, and all of which together shall constitute one and the same instrument.
 

 
[Signatures on Next Page]
 
 
3

 

 
This Agreement is executed and entered into this 31 st day of December, 2013.
 
Strategic Consultants International LLC
 
     /s/ Elizabeth Plaza                                                                                    
Name: Elizabeth Plaza
Title:
Pharma-Bio Serv, Inc.
 
         /s/ Pedro J. Lasanta                                                                                                
Name:  Pedro J. Lasanta
Title:   Chief Financial Officer and Vice-President – Finance and Administration
 
   /s/ Elizabeth Plaza                                                                                     
Elizabeth Plaza, individually
 


4